HIV gp41 mutants

Details HIV gp41 mutants HIV gp41 mutants

1995-06-06

1998-04-07

LeGuyader, John L.

Chemistry: molecular biology and microbiology

Vector, per se

514 44, 536 235, 536 2372, 930221, C12N 1549, C12N 1579, C07H 2104, A61K 4800

Patent

active

057363919

ABSTRACT:
Nucleic acid constructs encoding mutated human immunodeficiency virus gp41 polypeptides are described. The mutated polypeptides are effective to disrupt viral replication of HIV or disrupt the assembly of viral Env proteins in an HIV infected cell.

REFERENCES:
M.I. Johnston et al. (1993) Science 260:1286-1293.
D. Cournoyer et al. (1993) Annu. Rev. Immunol. 11:297-329.
M.B. Feinberg et al. (1992) AIDS Res. and Human Retrovir. 8(6):1013-1022.
J.A.T. Young et al. (1990) Science 250:1421-1423.
G.L. Buchschacher, Jr. et al (1992) Human Gene Therapy 3:391-397.
X. Yu et al. (Jul. 19-24, 1992) Int. Conf. AIDS 8(1):PTU31, (abstract No. TUA 0526).
J.W. Dubay et al (1989) J. Cell. Biochem. Suppl. 13 Part B: 268, (abstract G213).
J. W. Dubay et al. Truncation of the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein Cytoplasmic Domain Blocks Virus Infectivity vol. 66, No. 11, Nov. 1992, pp. 6616-6625.
Gabuzda et al., Effects of Deletions in the Cytoplasmic Domain on Biological Functions of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins, J. Virology 66:3306-3315, 1992.
Natsoulis and Boeke, New Antiviral Strategy Using Capsid-nuclease Fusion Proteins, Nature 352:632-635, 1991.
Pal et al., Myristoylation of gag Proteins of HIV-1 Plays an Important Role in Virus Assembly, AIDS Research and Human Retroviruses 6:721-730, 1990.
Smith et al., Human Immunodeficiency Virus Type 1 Pr55.sup.gag and Pr160.sup.gag-pol Expressed from a Simian Virus 40 Late Replacement Vector are . . . Assembled into Viruslike Particles, J. Virology 64:2743-2750, 1990.
Trono et al., HIV-1 Gag Mutants can Dominantly Interfere with the Replication of the Wild-Type Virus, Cell 59:113-120, 1989.
Arthos et al., Identification of the Residues in Human CD4 Critical for the Binding of HIV, Cell 57:469-481, 1989.
Dubay et al., Truncation of the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein Cytoplasmic Domain Blocks Virus Infectivity, J. Virology 66:6616-6625, 1992.
Earl et al., Biological and Immunological Properties of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein: Analysis of Proteins with . . . Recombinant Vaccinia Viruses J. Virology 65:31-41, 1991.
Freed et al., Characterization of the Fusion Domain of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp41, Proc. Natl. Acad. Sci. USA 87:4650-4654, 1990.
Freed et al., A Mutation in the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein gp41 Dominantly Interferes with Fusion and Infectivity, Proc. Natl. Acad. Sci. USA 1992.
Friedmann, Progress Toward Human Gene Therapy, Science 244:1275-1281, 1989.
Guy et al., A Specific Inhibitor of Cysteine Proteases Impairs a Vif-Dependent Modification of Human Immunodeficiency Virus Type 1 Env Protein, J. Virology 65:1325-1331, 1991.
Haffar et al., The Carboxy Terminus of Human Immunodeficiency Virus Type 1 gp160 Limits its Proteolytic Processing and Transport in Transfected Cell Lines.
Ivey-Hoyle et al., The N-terminal 31 Amino Acids of Human Immunodeficiency Virus Type 1 Envelope Protein gp120 Contain a Potential gp41 Contact Site, J. Virology 65:2682-2685, 1991.
Kowalski et al, Attenuation of Human Immunodeficiency Virus Type 1 Cytopathic Effect by a Mutation Affecting the Transmembrance Envelope Glycoprotein, J. Virology, 65:281-291, 1991.
Lasky et al., Delineation of a Region of the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein Critical for Interaction with the CD4 Receptor, Cell 50:975-985, 1987.
Lee et al., Role of the Carboxy-Terminal Portion of the HIV-1 Transmembrane Protein in Viral Transmission and Cytopathogencity, Aids Research and Human Retroviruses 5:441-449, 1989.
Shimizu et al., Analysis of a Human Immunodeficiency Virus Type 1 Isolate Carrying a Truncated Transmembrance Glycoprotein, Virology 189:534-546, 1992.

Affiliated with

Also associated with

Rating

HIV gp41 mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV gp41 mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV gp41 mutants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-12088